Ribosomal protein L23a pseudogene 89 (RPL23AP89)

Ribosomal protein L23a pseudogene 89 (RPL23AP89) is a non-coding pseudogene related to the ribosomal protein L23a gene but does not encode a functional protein. As a pseudogene, RPL23AP89 is generally considered functionless at the protein level and has not been shown to have clear biological activity or clinical significance. There is currently no evidence for its involvement in disease processes, its utility as a therapeutic target, or its use as a biomarker. Pseudogenes of ribosomal proteins, in general, are more often relevant as transcriptional noise or regulators of related genes at the RNA level, but no such regulatory role has been described for RPL23AP89. Most available biological and clinical studies focus instead on other ribosomal protein pseudogenes, such as RPL23AP53, which has been studied for expression changes in melanoma, but not as a druggable or functional target[1][4]. There is no published evidence of functional protein expression, receptor activity, or therapeutic interventions for RPL23AP89. If you need accurate information for drug discovery or therapeutic targeting, more attention should be given to canonical protein-coding genes or well-characterized functional RNAs, not to pseudogenes like RPL23AP89.

Other names

RPL23AP89Ribosomal protein L23a pseudogene 89

None known (There are no drugs targeting RPL23AP89 and, thus, no mechanisms of action defined)